16-Mar-2020 By Vassia Barba
Pfizer offers its resources to support research against the coronavirus under a five-point plan, calling for other companies to act accordingly.
18-Jul-2019 By Melissa Fassbender
The Pistoia Alliance launches a project to steer the implementation of principles for data management and stewardship, which it said are required as the industry undertakes a digital transformation.
13-May-2019 By Maggie Lynch
Mispro is expanding its vivarium service network with the opening of its fifth facility, an 18,000 square foot facility in Broad Hollow Bioscience Park, NY.
08-May-2019 By Maggie Lynch
The industrialized process the industry has developed over the years is not ready for the non-blockbuster environment its entering but AI can help, says Numerate executive.
28-Nov-2016 By Melissa Fassbender
Ideal Cures has added a fourth manufacturing location at Sikkim in India to meet the demand of its local customers and to expand its global customer base.
23-Aug-2016 By Dan Stanton
Increased cost pressures and a shift to biologics manufacturing are driving demand for automation technologies, says Zenith which is opening two offices in the US.
07-Mar-2016 By Gareth Macdonald
ANSM has banned Theravectys from manufacturing candidate vaccines and immunotherapies at its Paris facility until September after observing critical GMP deficiencies during an inspection last year.
Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress
04-Feb-2016 By Dan Stanton
Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.
12-Jan-2016 By Gareth Macdonald
UK pharma manufacturing output increased last year according to EEF, which says lower costs and a legacy of R&D investment will drive further growth in 2016.
11-Nov-2015 By Fiona BARRY
The UK biopharma industry is reporting difficulties finding manufacturing workers with the skills to make vaccines, biologics, and advanced therapy medicinal products (ATMP), according to ABPI.
Dispatches from ACHEMA 2015
18-Jun-2015 By Dan Stanton
The patent cliff and biopharmaceuticals have driven opportunities for pharma packaging companies, which say they are opting to grow through innovation rather than M&A.
08-Jul-2014 By Dan Stanton
M+W says a lack of synergies with its engineering and construction business drove the decision to sell its automation divison to ATS for €255m ($348m).
05-Jun-2014 By Dan Stanton
The Puerto Rico Industrial Development Company (PRIDCO) says Actavis’ investment at two facilities is evidence of continued pharma growth, despite a number of recent closures on the island.
10-Dec-2013 By Dan Stanton
Puerto Rico’s drug manufacturing industry has no future unless utility costs and taxes are controlled, according to a regulatory expert.
04-Jun-2013 By Zachary Brennan
Unither has agreed to acquire UCB’s manufacturing and packaging facility in Rochester, New York, and will produce UCB products at the site.
Production by Ireland’s pharmaceutical sector fell sharply in September but it is too early to say if it was part of a longer term decline, says the CSO
16-Oct-2012 By Rod Addy
SternMaid has invested €14m in its Wittenburg factory to enlarge capacity and extend the range of its products and services, involving the introduction of new fluid bed technology.
Novasep plans to build the ‘world’s largest’ chromatography-based API production plant with backing the French government, banks and gas firm Total.
19-Apr-2012 By Natalie Morrison
South Africa aims to boost its pharmaceutical production sector by developing a 70-strong list of oral solid dose drugs that it will only buy from local manufacturers.
Happy holidays from Outsourcing-pharma.com
Outsourcing.com would like to wish all our readers a happy holiday
US firm offering modular plant leases as alternative to CMOs
01-Dec-2011 By Nick Taylor
Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.
Biosimilar assessment a goal of FDA modernisation plan
18-Aug-2011 By Nick Taylor
The FDA is prioritising development of technologies to compare biosimilars to innovator products in its plan to modernise regulatory science.
FDA offers grant to improve biopharm production steps
13-Jul-2011 By Nick Taylor
The FDA is offering a grant to research projects that improve the reliability, speed and quality of biopharm production processes.
25-May-2011 By Gareth Macdonald
Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates.
25-May-2011 By Gareth Macdonald
The financial flexibility and quality standards of Indian CMOs should be enough to stave off competition from newer global contract manufacturing hubs, according to market research company RNCOS.
04-Apr-2011 By Gareth Macdonald
The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial Development Company (PRIDCO).
GSK joins UK Gov innovative manufacturing initiative
23-Mar-2011 By Nick Taylor
GSK is participating in a UK Government-backed innovative manufacturing initiative aimed at revitalising the sector.
Canada lost more than 3,600 pharma jobs in H2 2010
16-Feb-2011 By Nick Taylor
Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.
Lanxess opens Indian IER to meet demand for ultra pure water
07-Dec-2010 By Gareth Macdonald
Lanxess has opened an ion exchange resin production facility in India to cater for growing pharmaceutical manufacturing sector demand for ultrapure water.
bioMérieux exits Portland site production of prepared media, resulting job losses
02-Dec-2010 By Alexandria Pešić
bioMérieux will discontinue manufacturing media products for clinical applications and transfer production of other products made at its Portland, US, site elsewhere as part of a restructuring program.
12-Oct-2010 By Gareth Macdonald and Claire Videau
Recipharm says changes to Big Pharma and drug industry globalisation make having a worldwide manufacturing reach a virtual necessity for CDMOs.
PharmaZell expands manufacturing site in India
European contract manufacturing organisation (CMO) PharmaZell has increased capacity at its R&D centre in Vizag, India with a new cGMP Kilo-lab for API and drug intermediate production.
Kemwell boosts capacity with Sweden plant
19-May-2010 By Staff Reporter
Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity.
New Xcellerex CEO targets growth in revenues, clients
26-Apr-2010 By Nick Taylor
The incoming Xcellerex CEO plans to move the company from validation to penetration, boosting revenues and client base, and invest in the contract manufacturing side of the business.
Klockner expanding PVC and shrink-label capacity
31-Mar-2010 By Nick Taylor
The Klockner Pentaplast Group has invested $37m (€27m) to expand PVC production capacity and add shrink-label film capabilities at its facilities in Thailand and the US.
Ampac partners with Inabata and Codexis; Codexis teams with Dishman
18-Feb-2010 By Gareth Macdonald
Contract API maker Ampac Fine chemicals (AFC) has had a busy 24-hours, entering the Japanese market through a deal with Inabata and forging an alliance with Codexis on biocatalyst technology.
Pharmadule targets China with Morimatsu accord
04-Feb-2010 By Gareth Macdonald
Pharmadule has teamed up with Morimatsu to capture a share of Chinese pharma and biotech manufacturing markets’ “huge potential.”
Telangana plans disrupt GSK and Eisai in India
15-Dec-2009 By Gareth Macdonald
GSK halted production in Rajahmundry, India and Eisai postponed the opening of a facility in nearby Vizag on Saturday after days of unrest over plans to create a new state, Telangana, within Andhra Pradesh.
Leeds Uni opens £4m process development lab
01-Dec-2009 By Staff Reporter
Leeds University in the UK has unveiled a new £4m (€4.4m) laboratory designed to make small-scale process development “greener, cheaper and more effective.”
Ark to contract manufacture gene-based medicines
27-Aug-2009 By Nick Taylor
Ark Therapeutics is using its expertise and spare capacity to move into the contract manufacturing sector and is hoping to sign deals to produce the DNA-based medicine.
Rottapharm expanding Irish operations
01-Jul-2009 By Nick Taylor
Rottapharm is investing €7m ($9.8m) in its Irish manufacturing operations, which will create 35 jobs and add 2000 sq m housing three manufacturing and associated packaging lines.
11-Dec-2008 By Gareth Macdonald
The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing...
Domino’s unveils 5” printhead at Embellage
02-Dec-2008 By Gareth Macdonald
Domino Printing Sciences chose this year’s Emballage world packaging exhibition in Paris, France to showcase the new 5” printhead it has developed for its V300+ thermal transfer printer.
Shasun to shut down Scottish plant
India’s Shasun Pharma Solutions is to close its manufacturing facility in Annan, Scotland explaining that the site is being “underused,” according to media reports.
IndiaSoft gets DynoChem distribution contract
25-Jun-2008 By Garerth Macdonald
IndiaSoft Technologies, which is headquartered in the city of Pune
in Maharashtra state has won the contract to distribute Performance
Fluid Dynamics' (PFD) DynoChem productivity software to drug
manufacturers in the region.
Bosch plans to snap up Pharmatec
03-May-2007 By Anna Lewcock
The Bosch Group has announced plans to augment its packaging
technology division with the acquisition of German firm Pharmatec.
Rockwell invests in Ireland
05-Feb-2007 By Susan Gotensparre
US-based Rockwell Automation has acquired Irish engineering firm
ProsCon Holdings in a strategy to move into the European
Workhorse analytical tools to reduce human errors
22-Jan-2007 By Susan Gotensparre
Agilent Technologies has signed an agreement with Groton Biosystems
to co-market measuring solutions for the pharmaceutical industry,
as the Process Analytical Technology (PAT) initiative gains
popularity among drug manufacturers...
Pharma firms manufacturing waste costs $50bn, report warns
16-Oct-2006 By Emilie Reymond
The US pharmaceutical industry could be wasting more than $50bn
(€39bn) per year in manufacturing costs due to inefficient
processes, a new research has warned.
Optima's Interphex appearance details its future focus
29-Mar-2006 By Wai Lang Chu
The Optima Group's presence at this year's Interphex show in New
York was significant as it gave In-PharmaTechnologist.com the first
look at the Group's recently implemented shift in focus, resulting
in a product range...